DISEASE RISK ASSESSEMENT PROFILE

File: 102596_sep96_decls1_0010.txt
Page: 0010
Total Pages: 16

Subject: DISEASE RISK ASSESSEMENT PROFILE                                

Unit: VAR. BUMED  

Parent Organization: BUMED       

Box ID: BX303811

Folder Title: VARIOUS NAVAL MESSAGES FOLDER 1                                                                 

Document Number:          7

Folder SEQ  #:          2







               Immune Globulin (IG) for Hepatitis A is not routinely
            recommended for brief (several days) port visits in urban or
            tourist areas. One can minimize exposure to Hepatitis A by
            avoiding potentially contaminated water or food. Drinking water
            (and beverages with ice) of unknown purity, uncooked or partially
            cooked shellfish, and uncooked fruits or vegetables which are not
            peeled or prepared by the traveler should be avoided.

                Immune globulin (gamma globulin) is recommended, however,
            for those whose travel is outside usual tourist routes, those who
            may be unavoidably exposed to food or drinking water in settings
            of questionable sanitation (ex. certain local hosted parties),
            those who will be in contact with local young children in
            settings of poor sanitation, and to those who will be in-country
            for prolonged periods (several weeks). For such travelers, a
            single dose of IG prophylaxis of .02 ml/Kg (approx. two (2) cc
            deep intramuscular injection for the average adult) is recort-
            mended for travel less than three (3) months. For longer periods
            of travel, a different dosage, as well as other unrelated
            preventive medicine concerns, must be addressed and can be
            provided by NEPMU-7.

            6. Malaria

               Low to moderate risk. P. vivax infections are historically
            predominant and moderately endemic. Malaria risk is in the
            foothill areas and valleys in the mountainous regions of the
            northern emirates. There is no risk in the cities of Dubai,
            Sharjah, Ajman, Umm Al Qaiwan and Emirate of Abu Dhabi.    Histor-
            ically the greatest risk occurs in the populated coastal regions.
            Risk is year round. No drug resistance'is reported. Chenopro-
xis with chloro-
            quine/primaquine are recommended.

                NOTE: Primaquine should not be given to persons known to be
            G6PD defficient. Individuals who do not receive primacfuine
            should be counselled that they may experience a delayed case of
            relapsing (vivax or ovale) malaria weeks to years after exposure.
            All febrile episodes should be reported to a physician, who
            should be made aware of the possibility of malaria. In general,
            relapsing malaria is easily treated and not life-threatening.
            Personal Protective measures (such as proper clothing, DEET, and
            bed nets) should always be stressed.

               Medical Department personnel should review the laboratory and
            clinical diagnosis of malaria, as well as treatment.    An
            adequate supply of treatment drugs such as Fansidar, Quinine,
            and/or Mefloquine should be readily available. A recommended
            reference is the Navy Medical Department Guide to Malaria
            Prevention and Control.




                                            2

Document 16 f:/Week-37/BX303811/VARIOUS NAVAL MESSAGES FOLDER 1/disease risk assessement profile:1018961449592
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-37
Box ID = BX303811
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = VARIOUS NAVAL MESSAGES FOLDER 1
Folder Seq # = 2
Subject = DISEASE RISK ASSESSEMENT PROFILE
Document Seq # = 7
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 18-OCT-1996